These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2614856)

  • 1. Pharmacokinetic disposition of an immediate-release aminophylline and a sustained-release theophylline formulation in the horse.
    Goetz TE; Munsiff IJ; McKiernan BC
    J Vet Pharmacol Ther; 1989 Dec; 12(4):369-77. PubMed ID: 2614856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute bioavailability of theophylline from a sustained-release formulation using different intravenous reference infusions.
    Steinijans VW; Schulz HU; Böhm A; Beier W
    Eur J Clin Pharmacol; 1987; 33(5):523-6. PubMed ID: 3428347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
    Gupta S; Raina RK; Samotra K; Gupta KL
    Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.
    Horai Y; Ishizaki T; Sasaki T; Chiba K; Suganuma T; Echizen H; Ohnishi A
    Eur J Clin Pharmacol; 1983; 24(1):79-87. PubMed ID: 6832206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs.
    Bach JE; Kukanich B; Papich MG; McKiernan BC
    J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multiple-dose study of sustained-release theophylline and aminophylline.
    Meyer MC; Straughn AB; Lieberman P
    Chest; 1980 Aug; 78(2):300-3. PubMed ID: 7398417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bioavailability of theophylline in horses.
    Errecalde JO; Button C; Baggot JD; Mulders MS
    J Vet Pharmacol Ther; 1984 Dec; 7(4):255-63. PubMed ID: 6512916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained-release theophylline pharmacokinetics in the cat.
    Dye JA; McKiernan BC; Jones SD; Neff-Davis CA; Koritz GD
    J Vet Pharmacol Ther; 1989 Jun; 12(2):133-40. PubMed ID: 2746720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of a slow-release theophylline preparation in horses after intravenous and oral administration.
    Errecalde JO; Landoni MF
    Vet Res Commun; 1992; 16(2):131-8. PubMed ID: 1496815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of enteral feedings on sustained-release theophylline absorption.
    Plezia PM; Thornley SM; Kramer TH; Armstrong EP
    Pharmacotherapy; 1990; 10(5):356-61. PubMed ID: 2122422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
    Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of theophylline and ethylenediamine following single and repeated doses of a sustained-release aminophylline preparation to volunteers.
    Cotgreave IA; Caldwell J
    J Pharm Pharmacol; 1985 Sep; 37(9):618-21. PubMed ID: 2867181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic properties of theophylline given intravenously and orally to ruminating calves.
    Langston VC; Koritz GD; Davis LE; Neff-Davis C
    Am J Vet Res; 1989 Apr; 50(4):493-7. PubMed ID: 2712416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children.
    Rogers RJ; Kalisker A; Wiener MB; Szefler SJ
    J Pediatr; 1985 Mar; 106(3):496-501. PubMed ID: 3973788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea.
    Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theophylline pharmacokinetics in Thai children.
    Vichyanond P; Aranyanark N; Visitsuntorn N; Tuchinda M
    Asian Pac J Allergy Immunol; 1994 Dec; 12(2):137-43. PubMed ID: 7612107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from intravenous to oral dosing using sustained-release theophylline tablets.
    Stein GE; Haughey DB; Ross RJ; Vakoutis J
    Drug Intell Clin Pharm; 1982 Oct; 16(10):772-4. PubMed ID: 7140514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.
    Jonkman JH; van der Boon WJ; Balant LP; Schoenmaker R; Holtkamp A
    Eur J Clin Pharmacol; 1984; 26(2):215-22. PubMed ID: 6723760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.